The Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) recently proposed a set of rules to reclassify marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). This proposed rule set, announced on May 21, 2024, marks a significant shift in federal drug policy, reflecting an evolving understanding of marijuana’s medical use and its comparatively lower potential for abuse. Benzinga Cannabis did a comprehensive analysis of more than 4,000 public comments submitted until May 23, which revealed strong support for the DEA’s proposed rescheduling. Out of…
